For the quarter ended March 2026, Clorox (CLX Quick QuoteCLX - Free Report) reported revenue of $1.67 billion, up 0.1% over the same period last year. EPS came in at $1.64, compared to $1.45 in the year-ago quarter.

The reported revenue represents a surprise of +1.36% over the Zacks Consensus Estimate of $1.65 billion. With the consensus EPS estimate being $1.48, the EPS surprise was +10.83%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Clorox performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Organic sales growth - International: 2% versus the four-analyst average estimate of 6.4%.
• Organic sales growth - Lifestyle: -9% compared to the -2.3% average estimate based on four analysts.
• Organic sales growth - Household: 3% compared to the -3.1% average estimate based on four analysts.
• Organic sales growth (non-GAAP): -1% compared to the -0.9% average estimate based on four analysts.
• Net Sales- Health and Wellness: $629 million compared to the $621.26 million average estimate based on four analysts. The reported number represents a change of -0.2% year over year.
• Net Sales- International: $285 million versus the four-analyst average estimate of $281.06 million. The reported number represents a year-over-year change of +8.4%.
• Net Sales- Lifestyle: $277 million compared to the $299.12 million average estimate based on four analysts. The reported number represents a change of -9.5% year over year.
• Net Sales- Household: $482 million versus the four-analyst average estimate of $454.27 million. The reported number represents a year-over-year change of +2.8%.
• Income before income taxes- Health and Wellness: $158 million compared to the $164.16 million average estimate based on two analysts.
• Income before income taxes- Corporate and Other: $-32 million compared to the $-53.39 million average estimate based on two analysts.
• Income before income taxes- International: $36 million versus the two-analyst average estimate of $29.66 million.
• Income before income taxes- Lifestyle: $60 million versus $58.91 million estimated by two analysts on average.

View all Key Company Metrics for Clorox here>>>

Shares of Clorox have returned -9.1% over the past month versus the Zacks S&P 500 composite's +12.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.